News from us and our partners

Tags

Topics

0 results

News
25 July, 2024
deepc closes Series A extension to accelerate global deployment of healthcare AI, bringing total funding to $30m
News
25 July, 2024
Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
News
23 July, 2024
Sensorion announces positive recommendation from the Data Safety Monitoring Board (DSMB) regarding the continuation of NOTOXIS, its Phase 2a clinical trial of SENS-401 in cisplatin-induced ototoxicity
News
22 July, 2024
Strategic partnership for sustainable agriculture: Bayer and Elicit Plant join forces in France for maize cultivation
News
19 July, 2024
The keys to biotech success: people and relationships
News
18 July, 2024
Inventiva announces a €20.1 million issuance of royalty certificates
News
18 July, 2024
Chroma Medicine appoints renowned RNA scientist Melissa Moore to Board of Directors
News
16 July, 2024
Asceneuron secures $100 million Series C financing to advance ground breaking therapeutics in neurodegenerative diseases
News
15 July, 2024
CEO spotlight: Thierry Abribat's third straight win
News
15 July, 2024
Abivax provides operational and key program update
News
15 July, 2024
AstraZeneca closes acquisition of Amolyt Pharma
News
15 July, 2024
Sensorion announces new positive secondary efficacy endpoints data from SENS-401 Phase 2a clinical trial for the preservation of residual hearing loss
News
11 July, 2024
Bioptimus launches H-optimus-0, the world's largest open-source AI foundation model for pathology
News
9 July, 2024
HighLife welcomes Stefan Pilz as new Chief Executive Officer
News
9 July, 2024
Myricx Bio announces Board Changes
News
9 July, 2024
Mainstay Medical announces receipt of European and Australian approvals of MRI labeling on ReActiv8® Restorative Neurostimulation System™

deepc closes Series A extension to accelerate global deployment of healthcare AI, bringing total funding to $30m

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor

Sensorion announces positive recommendation from the Data Safety Monitoring Board (DSMB) regarding the continuation of NOTOXIS, its Phase 2a clinical trial of SENS-401 in cisplatin-induced ototoxicity

Strategic partnership for sustainable agriculture: Bayer and Elicit Plant join forces in France for maize cultivation

The keys to biotech success: people and relationships

Inventiva announces a €20.1 million issuance of royalty certificates

Chroma Medicine appoints renowned RNA scientist Melissa Moore to Board of Directors

Asceneuron secures $100 million Series C financing to advance ground breaking therapeutics in neurodegenerative diseases

CEO spotlight: Thierry Abribat's third straight win

Abivax provides operational and key program update

AstraZeneca closes acquisition of Amolyt Pharma

Sensorion announces new positive secondary efficacy endpoints data from SENS-401 Phase 2a clinical trial for the preservation of residual hearing loss

Bioptimus launches H-optimus-0, the world's largest open-source AI foundation model for pathology

HighLife welcomes Stefan Pilz as new Chief Executive Officer

Myricx Bio announces Board Changes

Mainstay Medical announces receipt of European and Australian approvals of MRI labeling on ReActiv8® Restorative Neurostimulation System™